We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
-7.59%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$351M
AUM Growth
-$186M
Cap. Flow
-$133M
Cap. Flow %
-37.85%
Top 10 Hldgs %
76.44%
Holding
207
New
37
Increased
22
Reduced
25
Closed
123

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$35.7M
2
MCK icon
McKesson
MCK
+$33M
3
ELV icon
Elevance Health
ELV
+$28.2M
4
EOG icon
EOG Resources
EOG
+$26.4M
5
NVO
Novo Nordisk
NVO
+$26.2M

Sector Composition

Rank Sector Weight
1 Healthcare 28.18%
2 Consumer Staples 20.19%
3 Technology 15.79%
4 Energy 12.08%
5 Financials 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
1
Procter & Gamble
PG
$347B
$36.5M 10.41%
254,121
+237,284
+1,409% +$35.7M
AAPL icon
2
Apple
AAPL
$4.77T
$33.9M 9.65%
247,894
-42,802
-15% -$6.48M
MCK icon
3
McKesson
MCK
$98.1B
$33.7M 9.59%
+103,170
New +$33M
ELV icon
4
Elevance Health
ELV
$83.6B
$27.6M 7.85%
+57,091
New +$28.2M
NVO
5
Novo Nordisk
NVO
$221B
$26.3M 7.49%
+471,708
New +$26.2M
KO icon
6
Coca-Cola
KO
$351B
$25.8M 7.34%
409,630
+408,030
+25,502% +$25.9M
EOG icon
7
EOG Resources
EOG
$75.3B
$23.5M 6.7%
+212,877
New +$26.4M
V icon
8
Visa
V
$686B
$22.9M 6.53%
116,415
+89,595
+334% +$18.5M
GD icon
9
General Dynamics
GD
$101B
$20.8M 5.94%
+94,204
New +$21.7M
CVX icon
10
Chevron
CVX
$378B
$17.4M 4.95%
119,988
+119,838
+79,892% +$19.8M
TXN icon
11
Texas Instruments
TXN
$262B
$12.2M 3.47%
+79,267
New +$13.3M
VZ icon
12
Verizon
VZ
$181B
$11.3M 3.22%
222,688
+200,407
+899% +$10.1M
MCD icon
13
McDonald's
MCD
$190B
$5.3M 1.51%
+21,478
New +$5.29M
COST icon
14
Costco
COST
$415B
$3.46M 0.98%
+7,210
New +$3.66M
TSLA icon
15
Tesla
TSLA
$1.4T
$3.09M 0.88%
+13,746
New +$3.75M
MSFT icon
16
Microsoft
MSFT
$2.97T
$2.78M 0.79%
10,822
-100,031
-90% -$27.1M
AMZN icon
17
Amazon
AMZN
$2.7T
$2.69M 0.77%
25,349
-125,531
-83% -$15.7M
SCHW
18
Charles Schwab
SCHW
$177B
$2.59M 0.74%
+40,988
New +$2.83M
JNJ icon
19
Johnson & Johnson
JNJ
$604B
$2.5M 0.71%
14,069
+2,640
+23% +$470K
BRK.B icon
20
Berkshire Hathaway Class B
BRK.B
$1.06T
$2.2M 0.63%
8,068
-77,525
-91% -$24.3M
LOCL icon
21
Local Bounti
LOCL
$27.1M
$1.92M 0.55%
+46,395
New +$3.42M
ABBV icon
22
AbbVie
ABBV
$448B
$1.75M 0.5%
11,438
-22,978
-67% -$3.51M
BMY icon
23
Bristol-Myers Squibb
BMY
$124B
$1.7M 0.49%
22,127
+1,477
+7% +$112K
XOM icon
24
ExxonMobil
XOM
$617B
$1.51M 0.43%
17,632
+17,354
+6,242% +$1.57M
CLX icon
25
Clorox
CLX
$11.6B
$1.41M 0.4%
10,015
+7,999
+397% +$1.14M

Similar funds

De Burlo Group's Q2 2022 Portfolio in Review

As of Q2 2022, De Burlo Group held 207 positions worth $351M, down 35% from $537M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

De Burlo Group withdrew a net $133M in Q2 2022, closing 123 positions and reducing 25 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 19% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, De Burlo Group opened a new position in McKesson worth $33.7M.

  • De Burlo Group's largest Q2 2022 buy was McKesson: 103,170 shares worth $33.7M.
  • De Burlo Group added most to Procter & Gamble in Q2 2022, an estimated $35.7M increase.
  • De Burlo Group's biggest Q2 2022 reduction was Microsoft, cutting an estimated $27.1M.
  • De Burlo Group fully exited Regeneron Pharmaceuticals in Q2 2022, selling an estimated $18.3M.
  • De Burlo Group's ten largest holdings make up 76% of its $351M portfolio in Q2 2022.
  • De Burlo Group opened 37 new positions and closed 123 in Q2 2022.
  • De Burlo Group's portfolio value fell 35% quarter-over-quarter to $351M.

Based on De Burlo Group's 13F filing for Q2 2022, filed 11 Aug 2022.